Diagnosis and treatment of trophoblastic disease. A report from the Southeastern Regional Center.
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002699:Chlorambucil / Q000627:therapeutic use; D002822:Choriocarcinoma / Q000188:drug therapy; D006063:Chorionic Gonadotropin / Q000097:blood; D003609:Dactinomycin / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006828:Hydatidiform Mole / Q000188:drug therapy; D002820:Hydatidiform Mole, Invasive / Q000188:drug therapy; D007044:Hysterectomy; D007263:Infusions, Parenteral; D007986:Luteinizing Hormone / Q000097:blood; D008727:Methotrexate / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011379:Prognosis; D014328:Trophoblastic Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000266:history / Q000601:surgery
D000970:Antineoplastic Agents; D006063:Chorionic Gonadotropin; D002699:Chlorambucil; D003609:Dactinomycin; D007986:Luteinizing Hormone; D008727:Methotrexate